Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01371604
What this trial is testing

Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks (MK-2355-005)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 68
Not applicableEnded earlyNCT00209755
What this trial is testing

Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Hopital A Michallon 40
Testing effectiveness (Phase 2)Study completedNCT00059358
What this trial is testing

Zidovudine Levels in HIV Infected Patients Being Treated for HCV

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 16
Not applicableUnknownNCT03042520
What this trial is testing

Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment

Who this might be right for
Liver FibrosesHepatoCellular CarcinomaCryoglobulinemia+2 more
Kaohsiung Medical University Chung-Ho Memorial Hospital 200
Testing effectiveness (Phase 2)Study completedNCT00084279
What this trial is testing

CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)

Who this might be right for
Chronic Hepatitis C
InterMune 81
Not applicableUnknownNCT06430190
What this trial is testing

Peginterferon α-2b Combined CO2 Laser in Condylomata Acuminata

Who this might be right for
Condylomata Acuminata
Zhangyu Bu 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT00539591
What this trial is testing

Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma

Who this might be right for
Malignant Melanoma
St. Jude Children's Research Hospital 29
Not applicableStudy completedNCT00000844
What this trial is testing

A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 560
Post-approval studies (Phase 4)UnknownNCT01731301
What this trial is testing

A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)

Who this might be right for
Chronic Hepatitis CEnd Stage Renal Disease
Liver Institute of Virginia 20
Testing effectiveness (Phase 2)UnknownNCT00027664
What this trial is testing

Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Cancer Research UK 90
Not applicableStudy completedNCT01142492
What this trial is testing

A Postmarketing Surveillance (PMS) Study to Evaluate the Extent to Which Patient Compliance is Influenced by Use of a Variable Titration Regimen at the Start of Treatment of Relapsing Multiple Sclerosis (MS) With Interferon Beta 1a (Rebif®)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 403
Large-scale testing (Phase 3)Study completedNCT02487199
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 18
Early research (Phase 1)Ended earlyNCT01636960
What this trial is testing

Pegylated Interferon Alfa-2b (MK-4031) as an Adjuvant Treatment in Japanese Patients With Malignant Melanoma (MK-4031-370)

Who this might be right for
Malignant Melanoma
Merck Sharp & Dohme LLC 9
Not applicableStudy completedNCT00749684
What this trial is testing

Efficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 138
Testing effectiveness (Phase 2)Study completedNCT00996476
What this trial is testing

Assess the Effectiveness, Safety, and Pharmacokinetics of TMC435 in Combination With Peginterferon Alfa-2a and Ribavirin in Hepatitis-C Infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 92
Early research (Phase 1)Looking for participantsNCT06582017
What this trial is testing

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Who this might be right for
Ovarian CancerPancreas CancerUrothelial Carcinoma+6 more
Nammi Therapeutics Inc 100
Not applicableWithdrawnNCT00838968
What this trial is testing

The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University
Not applicableUnknownNCT05622916
What this trial is testing

Topical Ethanol Extract (Piper Crocatum) for Anogenital Warts

Who this might be right for
Anogenital Wart
Hasanuddin University 100
Not applicableStudy completedNCT02533258
What this trial is testing

Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice

Who this might be right for
Renal Cell Carcinoma
Pfizer 13
Large-scale testing (Phase 3)WithdrawnNCT01797848
What this trial is testing

Efficacy and Safety Evaluation of a Treatment Consisting of Peg Interferon Alfa + Ribavirin + Daclatasvir in HCV Genotype 1 and 4 Treatment naïve Patients

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Next Page